Liquidia Inc. (LQDA) - יתרות מזומנים בחישוב למניה

Liquidia Corporation (LQDA) develops innovative powder medications to combat pulmonary hypertension, leveraging a streamlined supply chain and warehouse reserves. Cash per share demonstrates financial stability, where 4.36 captures the value of this parameter. Simultaneously, the company is implementing eco-design for inhalers and reducing harmful emissions while modernizing its production capacities.
פילוחים אנליטיים של חברת Liquidia (LQDA)

For Liquidia Corporation (LQDA), which is advancing the commercialization of pulmonary hypertension treatments, the balance between liquidity and expansion investments is critical. This metric is calculated by dividing total cash reserves by the number of shares outstanding, allowing for an assessment of the intrinsic value of an investor's stake. By analyzing the cash per share chart, one can determine the risk of inefficient capital allocation or the existence of a financial buffer to protect investments.